These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19915713)

  • 1. Dose Proportionality of Fentanyl Buccal Tablet in Healthy Japanese Volunteers.
    Darwish M; Tempero K; Jiang JG; Thompson J; Simonson PG
    Arch Drug Inf; 2008 Sep; 1(2):43-49. PubMed ID: 19915713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose proportionality of fentanyl buccal tablet in doses ranging from 600 to 1300 microg in healthy adult subjects: a randomized, open-label, four-period, crossover, single-centre study.
    Darwish M; Kirby M; Robertson P; Tracewell W; Xie F
    Clin Drug Investig; 2010; 30(6):365-73. PubMed ID: 20441245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative bioavailability of the fentanyl effervescent buccal tablet (FEBT) 1,080 pg versus oral transmucosal fentanyl citrate 1,600 pg and dose proportionality of FEBT 270 to 1,300 microg: a single-dose, randomized, open-label, three-period study in healthy adult volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Ther; 2006 May; 28(5):715-24. PubMed ID: 16861093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extent of Fentanyl Accumulation Following Multiple Doses of Fentanyl Buccal Tablet 400 microg in Healthy Japanese Volunteers.
    Darwish M; Tempero K; Jiang JG; Simonson PG
    Arch Drug Inf; 2008 Sep; 1(2):50-55. PubMed ID: 19915714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relative Bioavailability of Fentanyl Following Various Dosing Regimens of Fentanyl Buccal Tablet in Healthy Japanese Volunteers.
    Darwish M; Tempero K; Jiang JG; Simonson PG
    Arch Drug Inf; 2008 Sep; 1(2):56-62. PubMed ID: 19915709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence following buccal and sublingual placement of fentanyl buccal tablet 400 microg in healthy subjects.
    Darwish M; Kirby M; Jiang JG; Tracewell W; Robertson P
    Clin Drug Investig; 2008; 28(1):1-7. PubMed ID: 18081355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic properties of fentanyl effervescent buccal tablets: a phase I, open-label, crossover study of single-dose 100, 200, 400, and 800 microg in healthy adult volunteers.
    Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
    Clin Ther; 2006 May; 28(5):707-14. PubMed ID: 16861092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of buccal dwell time on the pharmacokinetic profile of fentanyl buccal tablet.
    Darwish M; Kirby M; Jiang JG
    Expert Opin Pharmacother; 2007 Sep; 8(13):2011-6. PubMed ID: 17714055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of equivalent doses of fentanyl buccal tablets and arteriovenous differences in fentanyl pharmacokinetics.
    Darwish M; Kirby M; Robertson P; Hellriegel E; Jiang JG
    Clin Pharmacokinet; 2006; 45(8):843-50. PubMed ID: 16884321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose proportionality and the effects of food on bioavailability of an immediate-release oxycodone hydrochloride tablet designed to discourage tampering and its relative bioavailability compared with a marketed oxycodone tablet under fed conditions: a single-dose, randomized, open-label, 5-way crossover study in healthy volunteers.
    Bass A; Stark JG; Pixton GC; Sommerville KW; Zamora CA; Leibowitz M; Rolleri R
    Clin Ther; 2012 Jul; 34(7):1601-12. PubMed ID: 22717418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A phase I, randomized, open-label, crossover study of the single-dose pharmacokinetic properties of guanfacine extended-release 1-, 2-, and 4-mg tablets in healthy adults.
    Swearingen D; Pennick M; Shojaei A; Lyne A; Fiske K
    Clin Ther; 2007 Apr; 29(4):617-25. PubMed ID: 17617285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and dose proportionality of fentanyl sublingual spray: a single-dose 5-way crossover study.
    Parikh N; Goskonda V; Chavan A; Dillaha L
    Clin Drug Investig; 2013 Jun; 33(6):391-400. PubMed ID: 23605506
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose proportionality and pharmacokinetics of fentanyl buccal soluble film in healthy subjects: a phase I, open-label, three-period, crossover study.
    Finn AL; Vasisht N; Stark JG; Gever LN; Tagarro I
    Clin Drug Investig; 2012 Jan; 32(1):63-71. PubMed ID: 22128878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of fentanyl from fentanyl buccal tablet in cancer patients with or without oral mucositis: a pilot study.
    Darwish M; Kirby M; Robertson P; Tracewell W; Jiang JG
    Clin Drug Investig; 2007; 27(9):605-11. PubMed ID: 17705569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of fentanyl buccal tablet: a pooled analysis and review.
    Darwish M; Xie F
    Pain Pract; 2012 Apr; 12(4):307-14. PubMed ID: 21831253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers.
    Kim TE; Kim BH; Kim J; Kim KP; Yi S; Shin HS; Lee YO; Lee KH; Shin SG; Jang IJ; Yu KS
    Clin Ther; 2009 Oct; 31(10):2249-57. PubMed ID: 19922896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and dose proportionality of fentanyl effervescent buccal tablets in healthy volunteers.
    Darwish M; Tempero K; Kirby M; Thompson J
    Clin Pharmacokinet; 2005; 44(12):1279-86. PubMed ID: 16372825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose Proportionality and Pharmacokinetics of Fentanyl Buccal Soluble Film in Healthy Subjects : A Phase I, Open-Label, Three-Period, Crossover Study.
    Finn AL; Vasisht N; Stark JG; Gever LN; Tagarro I
    Clin Drug Investig; 2012 Jan; 32(1):63-71. PubMed ID: 27933600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-dose bioequivalence of 105-mg fenofibric acid tablets versus 145-mg fenofibrate tablets under fasting and fed conditions: a report of two phase I, open-label, single-dose, randomized, crossover clinical trials.
    Godfrey AR; Digiacinto J; Davis MW
    Clin Ther; 2011 Jun; 33(6):766-75. PubMed ID: 21704241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.